BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B AND Staging
800 results:

  • 1. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
    Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
    [No Abstract]    [Full Text] [Related]  

  • 2. Defining distal splenopancreatectomy by the mesopancreas.
    Safi SA; Alexander A; Neuhuber W; Haeberle L; Rehders A; Luedde T; Esposito I; Fluegen G; Knoefel WT
    Langenbecks Arch Surg; 2024 Apr; 409(1):127. PubMed ID: 38625602
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas.
    Michalski K; Schlötelburg W; Hartrampf P; Heinrich M; Serfling S; Buck AK; Werner RA; Kosmala A; Weich A
    Mol Imaging Biol; 2024 Apr; 26(2):344-350. PubMed ID: 38332341
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Improved Clinical staging System for Localized pancreatic cancer Using the ABC Factors: A TAPS Consortium Study.
    Dekker EN; van Dam JL; Janssen QP; Besselink MG; DeSilva A; Doppenberg D; van Eijck CHJ; Nasar N; O'Reilly EM; Paniccia A; Prakash LR; Tzeng CD; Verkolf EMM; Wei AC; Zureikat AH; Katz MHG; Groot Koerkamp B;
    J Clin Oncol; 2024 Apr; 42(12):1357-1367. PubMed ID: 38315954
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Trends and disparities in access to minimally invasive distal pancreatectomy (midp): an eight-year analysis from the national cancer database.
    Jehan FS; Khreiss M; Seth A; Aziz H
    J Robot Surg; 2024 Jan; 18(1):52. PubMed ID: 38280048
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
    J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Registry-derived stage (RD-Stage) for capturing stage at diagnosis for pancreatic carcinoma in Australia.
    Evans SM; Ivanova K; Cossio D; Pilgrim CHC; Croagh D; Zalcberg J; Giffard D; Golobic N; Di Muzio B; McLean C C; McLean K; Miller GC; Nicosia S; O'Rourke N; Parikh S; Standish R; Te Marvelde L
    PLoS One; 2024; 19(1):e0294443. PubMed ID: 38166046
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
    Beck J; Siebenhüner A; Wild D; Christ E; Refardt J
    Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38117915
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery.
    Li B; Yin X; Ding X; Zhang G; Jiang H; Chen C; Guo S; Jin G
    BMC Surg; 2023 Dec; 23(1):370. PubMed ID: 38066512
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer.
    Shi W; Wartmann T; Accuffi S; Al-Madhi S; Perrakis A; Kahlert C; Link A; Venerito M; Keitel-Anselmino V; Bruns C; Croner RS; Zhao Y; Kahlert UD
    Br J Cancer; 2024 Jan; 130(1):125-134. PubMed ID: 37950093
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Fibroblast Activation Protein-Targeted PET/CT with
    Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
    J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic Impact of Minimal Pelvic Fluid in Locally Advanced pancreatic cancer: A Multicenter Retrospective Study.
    Lee J; Park JS; Jeong S; Lee DH; Lim JH; Cho SG; Kwon CI; Hyun JJ; Choe JW; Cho JH; Jang SI
    Turk J Gastroenterol; 2023 Dec; 34(12):1249-1256. PubMed ID: 37860834
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Reconsidering the absence of extrapancreatic extension in T staging for pancreatic adenocarcinoma in the AJCC (8
    Lee M; Thomas AS; Lee SY; Cho YJ; Jung HS; Yun WG; Han Y; Jang JY; Kluger MD; Kwon W
    J Gastrointest Surg; 2023 Nov; 27(11):2484-2492. PubMed ID: 37848688
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper gastrointestinal cancer patients.
    Jakobsen SS; Frøkjaer JB; Fisker RV; Kristensen SR; Thorlacius-Ussing O; Larsen AC
    J Thromb Thrombolysis; 2024 Jan; 57(1):11-20. PubMed ID: 37792208
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long-term cancer Survival Trends by Updated Summary Stage.
    Forjaz G; Ries L; Devasia TP; Flynn G; Ruhl J; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1508-1517. PubMed ID: 37623930
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis.
    Komiyama S; Okusaka T; Maruki Y; Ohba A; Nagashio Y; Kondo S; Hijioka S; Morizane C; Ueno H; Sukeda A; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Hiraoka N; Shimada K
    Intern Med; 2024 Apr; 63(7):891-901. PubMed ID: 37612088
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Bone Metastases in Patients with pancreatic NETs: Prevalence and Prognosis.
    Mathew A; Fendler WP; Theysohn J; Herrmann K; Führer D; Lahner H
    Horm Metab Res; 2023 Dec; 55(12):827-834. PubMed ID: 37611636
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Risk Stratification of pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy.
    Yang HK; Park MS; Han K; Eom G; Chung YE; Choi JY; Bang S; Kang CM; Seong J; Kim MJ
    Cancer Res Treat; 2024 Jan; 56(1):247-258. PubMed ID: 37605535
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma.
    Costentin C; Audureau E; Park YN; Langella S; Vibert E; Laurent A; Cauchy F; Scatton O; Chirica M; Rhaiem R; Boleslawski E; di Tommaso L; Ferrero A; Yano H; Akiba J; Donadon M; Nebbia M; Detry O; Honoré P; Di Martino M; Schwarz L; Barbier L; Nault JC; Rhee H; Lim C; Brustia R; Paradis V; Guettier C; Le Bail B; Okumura S; Blanc JF; Calderaro J
    Liver Int; 2023 Nov; 43(11):2538-2547. PubMed ID: 37577984
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 40.